Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Amarantus Bioscience Holdings, Inc. | Financial_Report.xls |
| EX-31.1 - EXHIBIT 31.1 - Amarantus Bioscience Holdings, Inc. | ex31_1.htm |
| EX-31.2 - EXHIBIT 31.2 - Amarantus Bioscience Holdings, Inc. | ex31_2.htm |
| EX-32.1 - EXHIBIT 32.1 - Amarantus Bioscience Holdings, Inc. | ex32_1.htm |
| 10-Q - MAINBODY - Amarantus Bioscience Holdings, Inc. | mainbody.htm |
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Amarantus BioScience Holdings, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Marc E. Faerber, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: May 15, 2013 | By: | /s/ Marc E. Faerber |
|
Marc E. Faerber Chief Financial Officer (Principal Financial and Accounting Officer) |